We hypothesized that miR-4429 could inhibit PCa progression through regulating DLX1 and the Wnt/β-catenin pathway, with gain- and loss-of function studies of these molecules performed to validate this hypothesis. Here, DLX1 is linked to posterior cortical atrophy.